Logo image of CLX

CLOROX COMPANY (CLX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CLX - US1890541097 - Common Stock

101.7 USD
+0.77 (+0.76%)
Last: 12/9/2025, 10:28:27 AM
Fundamental Rating

4

Overall CLX gets a fundamental rating of 4 out of 10. We evaluated CLX against 12 industry peers in the Household Products industry. While CLX is still in line with the averages on profitability rating, there are concerns on its financial health. CLX has a valuation in line with the averages, but it does not seem to be growing. Finally CLX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CLX was profitable.
CLX had a positive operating cash flow in the past year.
CLX had positive earnings in each of the past 5 years.
Each year in the past 5 years CLX had a positive operating cash flow.
CLX Yearly Net Income VS EBIT VS OCF VS FCFCLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 14.31%, CLX belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
With a decent Return On Invested Capital value of 21.90%, CLX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
CLX had an Average Return On Invested Capital over the past 3 years of 18.59%. This is above the industry average of 14.97%.
The last Return On Invested Capital (21.90%) for CLX is above the 3 year average (18.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROIC 21.9%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CLX Yearly ROA, ROE, ROICCLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100 200 300 400

1.3 Margins

The Profit Margin of CLX (11.68%) is better than 66.67% of its industry peers.
CLX's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 15.17%, CLX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
CLX's Operating Margin has declined in the last couple of years.
CLX's Gross Margin of 44.28% is fine compared to the rest of the industry. CLX outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of CLX has remained more or less at the same level.
Industry RankSector Rank
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CLX Yearly Profit, Operating, Gross MarginsCLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLX is creating value.
Compared to 1 year ago, CLX has less shares outstanding
CLX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLX has a worse debt to assets ratio.
CLX Yearly Shares OutstandingCLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CLX Yearly Total Debt VS Total AssetsCLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

CLX has an Altman-Z score of 3.10. This indicates that CLX is financially healthy and has little risk of bankruptcy at the moment.
CLX has a Altman-Z score (3.10) which is in line with its industry peers.
CLX has a debt to FCF ratio of 4.25. This is a neutral value as CLX would need 4.25 years to pay back of all of its debts.
The Debt to FCF ratio of CLX (4.25) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Altman-Z 3.1
ROIC/WACC2.82
WACC7.78%
CLX Yearly LT Debt VS Equity VS FCFCLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.76 indicates that CLX may have some problems paying its short term obligations.
With a Current ratio value of 0.76, CLX is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
CLX has a Quick Ratio of 0.76. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CLX (0.50) is worse than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.5
CLX Yearly Current Assets VS Current LiabilitesCLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

The earnings per share for CLX have decreased strongly by -10.99% in the last year.
The Earnings Per Share has been growing slightly by 1.01% on average over the past years.
Looking at the last year, CLX shows a decrease in Revenue. The Revenue has decreased by -9.35% in the last year.
CLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.11% yearly.
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%

3.2 Future

Based on estimates for the next years, CLX will show a small growth in Earnings Per Share. The EPS will grow by 1.55% on average per year.
CLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.20% yearly.
EPS Next Y-22.55%
EPS Next 2Y-5.91%
EPS Next 3Y-2.06%
EPS Next 5Y1.55%
Revenue Next Year-7.85%
Revenue Next 2Y-1.71%
Revenue Next 3Y-0.2%
Revenue Next 5Y1.2%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.13, CLX is valued correctly.
CLX's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.34. CLX is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 14.86, which indicates a correct valuation of CLX.
The rest of the industry has a similar Price/Forward Earnings ratio as CLX.
The average S&P500 Price/Forward Earnings ratio is at 23.56. CLX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.13
Fwd PE 14.86
CLX Price Earnings VS Forward Price EarningsCLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CLX's Enterprise Value to EBITDA is on the same level as the industry average.
CLX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 19.51
EV/EBITDA 11.72
CLX Per share dataCLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

CLX has a very decent profitability rating, which may justify a higher PE ratio.
CLX's earnings are expected to decrease with -2.06% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)14.94
EPS Next 2Y-5.91%
EPS Next 3Y-2.06%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.72%, CLX is a good candidate for dividend investing.
CLX's Dividend Yield is rather good when compared to the industry average which is at 3.35. CLX pays more dividend than 83.33% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, CLX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.72%

5.2 History

The dividend of CLX has a limited annual growth rate of 2.88%.
CLX has been paying a dividend for at least 10 years, so it has a reliable track record.
CLX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)2.88%
Div Incr Years34
Div Non Decr Years34
CLX Yearly Dividends per shareCLX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

76.11% of the earnings are spent on dividend by CLX. This is not a sustainable payout ratio.
The dividend of CLX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP76.11%
EPS Next 2Y-5.91%
EPS Next 3Y-2.06%
CLX Yearly Income VS Free CF VS DividendCLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CLX Dividend Payout.CLX Dividend Payout, showing the Payout Ratio.CLX Dividend Payout.PayoutRetained Earnings

CLOROX COMPANY

NYSE:CLX (12/9/2025, 10:28:27 AM)

101.7

+0.77 (+0.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners89.37%
Inst Owner Change-3.68%
Ins Owners0.4%
Ins Owner Change13.55%
Market Cap12.41B
Revenue(TTM)6.77B
Net Income(TTM)791.00M
Analysts54.81
Price Target131.24 (29.05%)
Short Float %5.56%
Short Ratio3.39
Dividend
Industry RankSector Rank
Dividend Yield 4.72%
Yearly Dividend4.88
Dividend Growth(5Y)2.88%
DP76.11%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-28 2026-01-28 (1.24)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.83%
Min EPS beat(2)6.97%
Max EPS beat(2)28.7%
EPS beat(4)3
Avg EPS beat(4)9.13%
Min EPS beat(4)-8.29%
Max EPS beat(4)28.7%
EPS beat(8)7
Avg EPS beat(8)25.3%
EPS beat(12)11
Avg EPS beat(12)52.89%
EPS beat(16)13
Avg EPS beat(16)41.78%
Revenue beat(2)2
Avg Revenue beat(2)1.32%
Min Revenue beat(2)1.06%
Max Revenue beat(2)1.58%
Revenue beat(4)3
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)2.62%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)9
Avg Revenue beat(12)2.28%
Revenue beat(16)11
Avg Revenue beat(16)1.58%
PT rev (1m)-3.62%
PT rev (3m)-7.08%
EPS NQ rev (1m)-0.88%
EPS NQ rev (3m)-6.14%
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-2.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 15.13
Fwd PE 14.86
P/S 1.83
P/FCF 19.51
P/OCF 14.54
P/B N/A
P/tB N/A
EV/EBITDA 11.72
EPS(TTM)6.72
EY6.61%
EPS(NY)6.84
Fwd EY6.73%
FCF(TTM)5.21
FCFY5.13%
OCF(TTM)6.99
OCFY6.88%
SpS55.51
BVpS-0.18
TBVpS-14.84
PEG (NY)N/A
PEG (5Y)14.94
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROCE 31.18%
ROIC 21.9%
ROICexc 22.99%
ROICexgc 49.37%
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
FCFM 9.39%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexgc growth 3Y25.21%
ROICexgc growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Debt/EBITDA 2.17
Cap/Depr 98.19%
Cap/Sales 3.2%
Interest Coverage 250
Cash Conversion 68.35%
Profit Quality 80.4%
Current Ratio 0.76
Quick Ratio 0.5
Altman-Z 3.1
F-Score6
WACC7.78%
ROIC/WACC2.82
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
EPS Next Y-22.55%
EPS Next 2Y-5.91%
EPS Next 3Y-2.06%
EPS Next 5Y1.55%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%
Revenue Next Year-7.85%
Revenue Next 2Y-1.71%
Revenue Next 3Y-0.2%
Revenue Next 5Y1.2%
EBIT growth 1Y-13.41%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year5.87%
EBIT Next 3Y7.05%
EBIT Next 5Y6.3%
FCF growth 1Y-19.9%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y-14.7%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%

CLOROX COMPANY / CLX FAQ

Can you provide the ChartMill fundamental rating for CLOROX COMPANY?

ChartMill assigns a fundamental rating of 4 / 10 to CLX.


What is the valuation status of CLOROX COMPANY (CLX) stock?

ChartMill assigns a valuation rating of 3 / 10 to CLOROX COMPANY (CLX). This can be considered as Overvalued.


What is the profitability of CLX stock?

CLOROX COMPANY (CLX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CLOROX COMPANY?

The Earnings per Share (EPS) of CLOROX COMPANY (CLX) is expected to decline by -22.55% in the next year.


Is the dividend of CLOROX COMPANY sustainable?

The dividend rating of CLOROX COMPANY (CLX) is 7 / 10 and the dividend payout ratio is 76.11%.